Status:
ACTIVE_NOT_RECRUITING
Long-term Use of CCB and Breast Cancer Risk
Lead Sponsor:
Curtin University
Conditions:
Hypertension,Essential
Breast Cancer
Eligibility:
FEMALE
45+ years
Brief Summary
The goal of this retrospective observational study is to examine whether long-term calcium channel blocker (CCB) use is associated with the development of breast cancer amongst women enrolled in three...
Detailed Description
Aims: To examine the association between long-term calcium channel blocker (CCB) use and the development of breast cancer. Data sources: the Australian Longitudinal Study on Women's Health , 45 and U...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Alive and still enrolled in the longitudinal cohort at the study entry (2004 to 2009)
- Self-reported/diagnosed hypertension at study entry.
- Exclusion criteria:
- \+ A history of breast cancer.
Exclusion
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
68500 Patients enrolled
Trial Details
Trial ID
NCT05972785
Start Date
July 1 2022
End Date
December 1 2025
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Curtin university
Bentley, Western Australia, Australia, 6102